The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Dedov I.I.

Endocrinology Research Centre

Peterkova V.A.

Éndokrinologicheskiĭ nauchnyĭ tsentr, Moskva

Karpushkina A.V.

The «CAF» Foundation for Fhilantropy Support and Development, Moscow

Charity Program «Alfa-Endo» for children with endocrine disease

Authors:

Dedov I.I., Peterkova V.A., Karpushkina A.V.

More about the authors

Journal: Problems of Endocrinology. 2015;61(2): 50‑54

Read: 817 times


To cite this article:

Dedov II, Peterkova VA, Karpushkina AV. Charity Program «Alfa-Endo» for children with endocrine disease. Problems of Endocrinology. 2015;61(2):50‑54. (In Russ.)
https://doi.org/10.14341/probl201561250-54

Recommended articles:

References:

  1. Dionisi-Vici С, Rizzo С, Burlina АВ. et al. Inborn errors of metabolosm in the Italian pediatric population: A national retrospective survey. The Journal of Pediatrics. 2002;140(3):321-329. doi: 10.1067/mpd.2002.122394.
  2. Schieppati A, Henter J-I, Daina E, Aperia A. Why rare diseases are an important medical and  social issue. The Lancet. 2008;371(9629):2039-2041. doi: 10.1016/s0140-6736(08)60872-7.
  3. van Weely S, Leufkens HGM. Orphan diseases. Background paper. In: prioruty medicines for Europe and the world. A public health approach to innovation. http://mednet3.who. int/prioritymeds/report/index.htm#c.
  4. Eurordis . EurordisCare2: survey of diagnostic delays, 8 diseases, Europe, http://www.eurordis.org/big_article.php37id_article=454.
  5. Forum donorov. Doklad o sostojanii i razvitii v Rossii. 2013.
  6. VOZ. Zdorov’e-2020: osnovy Evropejskoj politiki v podderzhku dejsrtvij vsego gosudarstva i obshhestva v interasah zdorov’ja i blagopoluchija.
  7. Medicines and Healthcare Products Regulatory. Good Laboratory Practice. http://www.mhra.gov.uk/Howweregulate/Medicines/Inspectionandstandards/GoodLaboratoryPractice/ind ex.htm.
  8. Nacional’nyj standart RF GOST R 53022.1-2008  «Tehnologii laboratornye klinicheskie. Trebovanija k kachestvu klinicheskih laboratornyh issledovanij. Chast’ 1. Pravila menedzhmenta kachestva klinicheskih laboratornyh issledovanij» (utverzhden Prikazom Rostehregulirovanija №355-st ot 04.12.08).
  9. Hofgartner WT, Tait JF. Characteristics of clinical molecular-genetic testing laboratories in the Unated Stated. Clin Chem. 1999;45:1288-1290.
  10. McGovern MM, Elies R, Beretta I. et al. Report of an International Survey of Molecular Genetic Testing Laboratories. Community Genetics. 2007;10(3):123-131. doi:10.1159/000101753.
  11. Hudson KL, Murphy JA, Kaufman DJ. et al. Oversight of US genetic tsting laboratories. Nature Biotechnology. 2006;24(9):1083-1090. doi: 10.1038/nbt0906-1083.
  12. McGovern MM. Quality Assurance in Molocular Genetic testing Laboratories. Jama. 1999;281(9):835. doi: 10.1001/jama.281.9.835.
  13. McGovern MM, Benach M, Wallenstein S. et al. Personnel standards and quality assurance practices of biochemical genetic testing laboratories in the United States. Arch Pathol Lab Med. 2003;127(l):71-76. doi: 10.1043/0003-9985(2003) 127<71:PSAQAP>2.0.CO;2.
  14. Howanitz PJ, Tetrault GA, Steindel SJ. Clinical laboratory quality control: a costly process now out of control. Clinica Chimica Acta. 1997;260(2): 163-174. doi: 10.1016/s0009-8981(96)06494-7.
  15. McGovern MM, Elies R, Beretta I. et al. Report of an International Survey of Molecular Genetic Testing Laboratories. Community Genetics. 2007;10(3):123-131. doi: 10.1159/000101753.
  16. Laboratory Practices for Molecular Genetic Testing for Heritable Diseases and Conditions.
  17. Guidelines for Quality Assurance in Molecular Genetic Testing.
  18. Provost LP, MurrayS. The Health Care Data Guide: Learning from Data for Improvement. 2011, Jossey-Bass.
  19. Shaw C, Kalo I. A backgroum for national quality policies in health systems. Copenhagen, WHO Regional Office for Europe. 2002.
  20. Scott I. What are the most effective strategies for improving quality and safery of health care? Internal Medicine Journal. 2009;39(6):389-400. doi: 10.1111/j.1445-5994.2008.01798.x.
  21. Farrow R, Norman G. The effectiveness of PBL: the debate continues. Is metaanalysis helpful? Medical Education. 2003;37(12):1131-1132. doi: 10.1046/j/1365-2923.2003.01725.x.
  22. Neville AJ. Problem-based learning and medical education forty years on. A review of its effects on knowledge and clinical performance. Med Princ Pract. 2009;18(1):1-9. doi:10.1159/000163038.
  23. Sanson-Fisher RW, Lynagh MC. Problem-basec learning: a dissemination success story? Med J Aust. 2005;183(5):258-260.
  24. Cantillon P. Teaching large groups. Bmj. 2003;326(7386):437. doi:10.1136/bmj.326.7386.437.
  25. Jaques D. ABC of learning and teaching in medicine: Teaching small groups. Bmj. 2003;326(7387):492-494. doi: 10.1136/bmj.326.7387.492.
  26. Michael J. Where’s the evidence that active learing works? Adv Physiol Educt. 2006;30:159-167.
  27. Michaelsen LK, Fink LD. Team-based Learning: Small group learning’s next big step. New Directions for Teaching and Learning. 2008;116:1-104.
  28. Norman G. What’s the active ingredient in active learning? Adv Health Sci Educ Theory Pract. 2004;9(l):l-3.
  29. Scott I. What are the most effective strategies for improving qualty and safery of health care. Internal Medicine Journal.2009;39:389-400.
  30. Diabetes UK (2005) Resources to support the delivery of care for children and yung people with Diabetes//www.diabetes.org.uk/Documents/Shared%20pra %2006.pdf.
  31. Guidance on the use of patient-education models for diabetes. 2008.
  32. Interventions for preventing obesity in children. Cochrane Public Health Grpup.

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.